Schedule 13G ownership disclosure

Vanda Pharmaceuticals Inc

Security class unavailable · CUSIP: 921659108

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,230,548
Percent of class
7.7400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001306923-21-000020
Form type
SC 13G/A
Filer
Palo Alto Investors LP
CIK
CIK 1306923
Filed
Feb 16, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub